RNAi Technology Market

研究執行與發布：Grand View Research　·　發布日期 2026-08-28　·　120 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

完整報告名稱與涵蓋範圍

RNAi Technology Market Size, Share & Trends Analysis Report By Product & Services (Products, Services), By Application (Drug Discovery & Development, Functional Genomics), By End Use, By Region, And Segment Forecasts, 2026 - 2033

報告摘要

RNAi Technology Market Summary The global RNAi technology market size was valued at USD 3.3 billion in 2025 and is projected to grow from USD 3.7 billion in 2026 to USD 9.5 billion by 2033, at a CAGR of 14.6% from 2026 to 2033. North America dominated the global market, accounting for the largest revenue share of 38.3% in 2025. The market growth can be attributed to the increasing prevalence of autoimmune diseases, rare disorders, and cancer across the globe. Global RNAi Technology Market Report Segmentation This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global RNAi technology market report based on product & service, application, end use, and region: • Product & Service Outlook (Revenue, USD Million/Billion, 2021 - 2033) • Products o siRNA products o miRNA products o Others • Services • Application Outlook (Revenue, USD Million/Billion, 2021 - 2033) • Drug Discovery & Development o Neurology o Oncology o Infectious Diseases o Metabolic Diseases o Others • Functional Genomics • Others • End Use Outlook (Revenue, USD Million/Billion, 2021 - 2033) • Pharmaceutical & Biotechnology Companies • Academic & Research Institutes • CROs & CMOs • Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033) • North America o U.S. o Canada o Mexico • Europe o UK o Germany o France o Italy o Spain o Denmark o Sweden o Norway • Asia Pacific o Japan o China o India o Australia o Thailand o South Korea • Latin America o Brazil o Argentina • Middle East and Africa (MEA) o South Africa o Saudi Arabia o UAE o Kuwait

授權報價

Single User License	$5,950 USD
Enterprise License	$6,950 USD
Corporate User License	$8,950 USD

目錄 Table of Contents

Table of Contents Chapter 1. Methodology and Scope 1.1. Market Segmentation and Scope 1.1.1. Segment Definitions 1.1.1.1. Products & Service Segment 1.1.1.2. Application Segment 1.1.1.3. End Use Segment 1.2. Regional Scope 1.3. Estimates and Forecast Timeline 1.4. Objectives 1.5. Research Methodology 1.6. Information Procurement 1.6.1. Purchased Database 1.6.2. GVR’s Internal Database 1.6.3. Secondary Sources 1.6.4. Primary Research 1.7. Information or Data Analysis: 1.7.1. Data Analysis Models 1.8. Market Formulation & Validation 1.9. Model Details 1.9.1. Commodity Flow Analysis 1.9.2. List of Secondary Sources 1.9.3. List of Abbreviations Chapter 2. Executive Summary 2.1. Market Snapshot 2.2. Segment Snapshot 2.3. Competitive Landscape Snapshot Chapter 3. Market Variables, Trends, & Scope 3.1. Market Lineage Outlook 3.1.1. Parent Market Outlook 3.1.2. Related/Ancillary Market Outlook 3.2. Market Dynamics 3.2.1. Market Driver Analysis 3.2.1.1. Technological Advancements in RNAi Techniques 3.2.1.2. Increasing Application of RNAi Technology in Research and Medicine 3.2.1.3. Growing Demand for Precision Therapeutics 3.2.2. Market Restraint Analysis 3.2.2.1. High Development and Manufacturing Costs 3.2.2.2. Challenges Associated with Efficient RNAi Delivery Systems 3.2.2.3. Off-Target Effects and Safety Concerns 3.2.3. Market Opportunities Analysis 3.2.4. Market Challenges Analysis 3.3. Industry Analysis Tools 3.3.1. Porter’s Five Forces Analysis 3.3.2. PESTLE Analysis Chapter 4. Product & Service Business Analysis 4.1. Segment Dashboard 4.2. RNAi Technology Market: Product & Service Movement Analysis 4.3. Products 4.3.1. Products Market, 2021–2033 (USD Million/Billion) 4.3.2. siRNA Products 4.3.2.1. siRNA Products Market, 2021–2033 (USD Million/Billion) 4.3.3. miRNA Products 4.3.3.1. miRNA Products Market, 2021–2033 (USD Million/Billion) 4.3.4. Others 4.3.4.1. Others Market, 2021–2033 (USD Million/Billion) 4.4. Services 4.4.1. Services Market, 2021–2033 (USD Million/Billion) Chapter 5. Application Business Analysis 5.1. Segment Dashboard 5.2. RNAi Technology Market: Application Movement Analysis 5.3. Drug Discovery & Development 5.3.1. Drug Discovery & Development Market, 2021–2033 (USD Million/Billion) 5.3.2. Neurology 5.3.2.1. Neurology Market, 2021–2033 (USD Million/Billion) 5.3.3. Oncology 5.3.3.1. Oncology Market, 2021–2033 (USD Million/Billion) 5.3.4. Infectious Diseases 5.3.4.1. Infectious Diseases Market, 2021–2033 (USD Million/Billion) 5.3.5. Metabolic Diseases 5.3.5.1. Metabolic Diseases Market, 2021–2033 (USD Million/Billion) 5.3.6. Others 5.3.6.1. Others Market, 2021–2033 (USD Million/Billion) 5.4. Functional Genomics 5.4.1. Functional Genomics Market, 2021–2033 (USD Million/Billion) 5.5. Others 5.5.1. Others Market, 2021–2033 (USD Million/Billion) Chapter 6. End Use Business Analysis 6.1. Segment Dashboard 6.2. RNAi Technology Market: End Use Movement Analysis 6.3. Pharmaceutical & Biotechnology Companies 6.3.1. Pharmaceutical & Biotechnology Companies Market, 2021–2033 (USD Million/Billion) 6.4. Academic & Research Institutes 6.4.1. Academic & Research Institutes Market, 2021–2033 (USD Million/Billion) 6.5. CROs & CMOs 6.5.1. CROs & CMOs Market, 2021–2033 (USD Million/Billion) Chapter 7. Regional Business Analysis 7.1. RNAi Technology Market Share By Region, 2025 & 2033 7.2. North America 7.2.1. North America RNAi Technology Market, 2021 - 2033 (USD Million/Billion) 7.2.2. U.S. 7.2.2.1. Key Country Dynamics 7.2.2.2. Competitive Scenario 7.2.2.3. Regulatory Framework 7.2.2.4. U.S. RNAi Technology Market, 2021 - 2033 (USD Million/Billion) 7.2.3. Canada 7.2.3.1. Key Country Dynamics 7.2.3.2. Competitive Scenario 7.2.3.3. Regulatory Framework 7.2.3.4. Canada RNAi Technology Market, 2021 - 2033 (USD Million/Billion) 7.2.4. Mexico 7.2.4.1. Key Country Dynamics 7.2.4.2. Competitive Scenario 7.2.4.3. Regulatory Framework 7.2.4.4. Mexico RNAi Technology Market, 2021 - 2033 (USD Million/Billion) 7.3. Europe 7.3.1. Europe RNAi Technology Market, 2021 - 2033 (USD Million/Billion) 7.3.2. UK 7.3.2.1. Key Country Dynamics 7.3.2.2. Competitive Scenario 7.3.2.3. Regulatory Framework 7.3.2.4. UK RNAi Technology Market, 2021 - 2033 (USD Million/Billion) 7.3.3. Germany 7.3.3.1. Key Country Dynamics 7.3.3.2. Competitive Scenario 7.3.3.3. Regulatory Framework 7.3.3.4. Germany RNAi Technology Market, 2021 - 2033 (USD Million/Billion) 7.3.4. France 7.3.4.1. Key Country Dynamics 7.3.4.2. Competitive Scenario 7.3.4.3. Regulatory Framework 7.3.4.4. France RNAi Technology Market, 2021 - 2033 (USD Million/Billion) 7.3.5. Italy 7.3.5.1. Key Country Dynamics 7.3.5.2. Competitive Scenario 7.3.5.3. Regulatory Framework 7.3.5.4. Italy RNAi Technology Market, 2021 - 2033 (USD Million/Billion) 7.3.6. Spain 7.3.6.1. Key Country Dynamics 7.3.6.2. Competitive Scenario 7.3.6.3. Regulatory Framework 7.3.6.4. Spain RNAi Technology Market, 2021 - 2033 (USD Million/Billion) 7.3.7. Denmark 7.3.7.1. Key Country Dynamics 7.3.7.2. Competitive Scenario 7.3.7.3. Regulatory Framework 7.3.7.4. Denmark RNAi Technology Market, 2021 - 2033 (USD Million/Billion) 7.3.8. Sweden 7.3.8.1. Key Country Dynamics 7.3.8.2. Competitive Scenario 7.3.8.3. Regulatory Framework 7.3.8.4. Sweden RNAi Technology Market, 2021 - 2033 (USD Million/Billion) 7.3.9. Norway 7.3.9.1. Key Country Dynamics 7.3.9.2. Competitive Scenario 7.3.9.3. Regulatory Framework 7.3.9.4. Norway RNAi Technology Market, 2021 - 2033 (USD Million/Billion) 7.4. Asia Pacific 7.4.1. Asia Pacific RNAi Technology Market, 2021 - 2033 (USD Million/Billion) 7.4.2. Japan 7.4.2.1. Key Country Dynamics 7.4.2.2. Competitive Scenario 7.4.2.3. Regulatory Framework 7.4.2.4. Japan RNAi Technology Market, 2021 - 2033 (USD Million/Billion) 7.4.3. China 7.4.3.1. Key Country Dynamics 7.4.3.2. Competitive Scenario 7.4.3.3. Regulatory Framework 7.4.3.4. China RNAi Technology Market, 2021 - 2033 (USD Million/Billion) 7.4.4. India 7.4.4.1. Key Country Dynamics 7.4.4.2. Competitive Scenario 7.4.4.3. Regulatory Framework 7.4.4.4. India RNAi Technology Market, 2021 - 2033 (USD Million/Billion) 7.4.5. Australia 7.4.5.1. Key Country Dynamics 7.4.5.2. Competitive Scenario 7.4.5.3. Regulatory Framework 7.4.5.4. Australia RNAi Technology Market, 2021 - 2033 (USD Million/Billion) 7.4.6. Thailand 7.4.6.1. Key Country Dynamics 7.4.6.2. Competitive Scenario 7.4.6.3. Regulatory Framework 7.4.6.4. Thailand RNAi Technology Market, 2021 - 2033 (USD Million/Billion) 7.4.7. South Korea 7.4.7.1. Key Country Dynamics 7.4.7.2. Competitive Scenario 7.4.7.3. Regulatory Framework 7.4.7.4. South Korea RNAi Technology Market, 2021 - 2033 (USD Million/Billion) 7.5. Latin America 7.5.1. Latin America RNAi Technology Market, 2021 - 2033 (USD Million/Billion) 7.5.2. Brazil 7.5.2.1. Key Country Dynamics 7.5.2.2. Competitive Scenario 7.5.2.3. Regulatory Framework 7.5.2.4. Brazil RNAi Technology Market, 2021 - 2033 (USD Million/Billion) 7.5.3. Argentina 7.5.3.1. Key Country Dynamics 7.5.3.2. Competitive Scenario 7.5.3.3. Regulatory Framework 7.5.3.4. Argentina RNAi Technology Market, 2021 - 2033 (USD Million/Billion) 7.6. MEA 7.6.1. MEA RNAi Technology Market, 2021 - 2033 (USD Million/Billion) 7.6.2. South Africa 7.6.2.1. Key Country Dynamics 7.6.2.2. Competitive Scenario 7.6.2.3. Regulatory Framework 7.6.2.4. South Africa RNAi Technology Market, 2021 - 2033 (USD Million/Billion) 7.6.3. Saudi Arabia 7.6.3.1. Key Country Dynamics 7.6.3.2. Competitive Scenario 7.6.3.3. Regulatory Framework 7.6.3.4. Saudi Arabia RNAi Technology Market, 2021 - 2033 (USD Million/Billion) 7.6.4. UAE 7.6.4.1. Key Country Dynamics 7.6.4.2. Competitive Scenario 7.6.4.3. Regulatory Framework 7.6.4.4. UAE RNAi Technology Market, 2021 - 2033 (USD Million/Billion) 7.6.5. Kuwait 7.6.5.1. Key Country Dynamics 7.6.5.2. Competitive Scenario 7.6.5.3. Regulatory Framework 7.6.5.4. Kuwait RNAi Technology Market, 2021 - 2033 (USD Million/Billion) Chapter 8. Competitive Landscape 8.1. Company Categorization 8.2. Strategy Mapping 8.3. Company Market Share/ Position Analysis, 2025 8.4. Company Profiles/Listing 8.4.1. Thermo Fisher Scientific, Inc. 8.4.1.1. Overview 8.4.1.2. Financial Performance 8.4.1.3. Product Benchmarking 8.4.1.4. Strategic Initiatives 8.4.2. Merck KGaA 8.4.2.1. Overview 8.4.2.2. Financial Performance 8.4.2.3. Product Benchmarking 8.4.2.4. Strategic Initiatives 8.4.3. Creative Biolabs 8.4.3.1. Overview 8.4.3.2. Financial Performance 8.4.3.3. Product Benchmarking 8.4.3.4. Strategic Initiatives 8.4.4. GenScript 8.4.4.1. Overview 8.4.4.2. Financial Performance 8.4.4.3. Product Benchmarking 8.4.4.4. Strategic Initiatives 8.4.5. Revvity 8.4.5.1. Overview 8.4.5.2. Financial Performance 8.4.5.3. Product Benchmarking 8.4.5.4. Strategic Initiatives 8.4.6. Promega Corporation 8.4.6.1. Overview 8.4.6.2. Financial Performance 8.4.6.3. Product Benchmarking 8.4.6.4. Strategic Initiatives 8.4.7. OriGene Technologies, Inc. 8.4.7.1. Overview 8.4.7.2. Financial Performance 8.4.7.3. Product Benchmarking 8.4.7.4. Strategic Initiatives 8.4.8. Altogen Biosystems 8.4.8.1. Overview 8.4.8.2. Financial Performance 8.4.8.3. Product Benchmarking 8.4.8.4. Strategic Initiatives 8.4.9. Danaher 8.4.9.1. Overview 8.4.9.2. Financial Performance 8.4.9.3. Product Benchmarking 8.4.9.4. Strategic Initiatives 8.4.10. Bioneer Corporation 8.4.10.1. Overview 8.4.10.2. Financial Performance 8.4.10.3. Product Benchmarking 8.4.10.4. Strategic Initiatives

圖表清單 List of Tables & Figures

List of Tables Table 1 List of secondary sources Table 2 List of abbreviations Table 3 Global RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 4 Global RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 5 Global RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) Table 6 Global RNAi technology market, by region, 2021 - 2033 (USD Million/Billion) Table 7 North America RNAi technology market, by country, 2021 - 2033 (USD Million/Billion) Table 8 North America RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 9 North America RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 10 North America RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) Table 11 U.S. RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 12 U.S. RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 13 U.S. RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) Table 14 Canada RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 15 Canada RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 16 Canada RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) Table 17 Mexico RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 18 Mexico RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 19 Mexico RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) Table 20 Europe RNAi technology market, by country, 2021 - 2033 (USD Million/Billion) Table 21 Europe RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 22 Europe RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 23 Europe RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) Table 24 UK RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 25 UK RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 26 UK RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) Table 27 Germany RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 28 Germany RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 29 Germany RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) Table 30 France RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 31 France RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 32 France RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) Table 33 Italy RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 34 Italy RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 35 Italy RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) Table 36 Spain RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 37 Spain RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 38 Spain RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) Table 39 Denmark RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 40 Denmark RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 41 Denmark RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) Table 42 Sweden RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 43 Sweden RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 44 Sweden RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) Table 45 Norway RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 46 Norway RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 47 Norway RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) Table 48 Asia Pacific RNAi technology market, by country, 2021 - 2033 (USD Million/Billion) Table 49 Asia Pacific RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 50 Asia Pacific RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 51 Asia Pacific RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) Table 52 Japan RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 53 Japan RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 54 Japan RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) Table 55 China RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 56 China RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 57 China RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) Table 58 India RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 59 India RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 60 India RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) Table 61 Australia RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 62 Australia RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 63 Australia RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) Table 64 Thailand RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 65 Thailand RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 66 Thailand RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) Table 67 South Korea RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 68 South Korea RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 69 South Korea RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) Table 70 Latin America RNAi technology market, by country, 2021 - 2033 (USD Million/Billion) Table 71 Latin America RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 72 Latin America RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 73 Latin America RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) Table 74 Brazil RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 75 Brazil RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 76 Brazil RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) Table 77 Argentina RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 78 Argentina RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 79 Argentina RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) Table 80 Middle East & Africa RNAi technology market, by country, 2021 - 2033 (USD Million/Billion) Table 81 Middle East & Africa RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 82 Middle East & Africa RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 83 Middle East & Africa RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) Table 84 South Africa RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 85 South Africa RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 86 South Africa RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) Table 87 Saudi Arabia RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 88 Saudi Arabia RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 89 Saudi Arabia RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) Table 90 UAE RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 91 UAE RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 92 UAE RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) Table 93 Kuwait RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion) Table 94 Kuwait RNAi technology market, by application, 2021 - 2033 (USD Million/Billion) Table 95 Kuwait RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion) List of Figures Fig. 1 RNAi technology market segmentation Fig. 2 Market research process Fig. 3 Data triangulation techniques Fig. 4 Primary research pattern Fig. 5 Market research approaches Fig. 6 Market formulation & validation Fig. 7 Market outlook Fig. 8 Segment snapshot Fig. 9 Competitive landscape snapshot Fig. 10 Parent market outlook Fig. 11 RNAi technology market driver analysis Fig. 12 RNAi technology market restraint analysis Fig. 13 RNAi technology market: Porter's five forces analysis Fig. 14 RNAi technology market: PESTLE analysis Fig. 15 RNAi technology market: Product & Service outlook and key takeaways Fig. 16 RNAi technology market: Product & Service market share analysis Fig. 17 Products market, 2021 - 2033 (USD Million/Billion) Fig. 18 miRNA products market, 2021 - 2033 (USD Million/Billion) Fig. 19 siRNA products market, 2021 - 2033 (USD Million/Billion) Fig. 20 Others market, 2021 - 2033 (USD Million/Billion) Fig. 21 Services market, 2021 - 2033 (USD Million/Billion) Fig. 22 RNAi technology market: Application outlook and key takeaways Fig. 23 RNAi technology market: Application market share analysis Fig. 24 Drug discovery & development market, 2021 - 2033 (USD Million/Billion) Fig. 25 Neurology market, 2021 - 2033 (USD Million/Billion) Fig. 26 Oncology market, 2021 - 2033 (USD Million/Billion) Fig. 27 Infectious diseases market, 2021 - 2033 (USD Million/Billion) Fig. 28 Metabolic diseases market, 2021 - 2033 (USD Million/Billion) Fig. 29 Others market, 2021 - 2033 (USD Million/Billion) Fig. 30 Functional genomics market, 2021 - 2033 (USD Million/Billion) Fig. 31 Others market, 2021 - 2033 (USD Million/Billion) Fig. 32 RNAi technology market: End use outlook and key takeaways Fig. 33 RNAi technology market: End use market share analysis Fig. 34 Pharmaceutical & biotechnology companies market, 2021 - 2033 (USD Million/Billion) Fig. 35 Academic & research institutes market, 2021 - 2033 (USD Million/Billion) Fig. 36 CROs & CMOs market, 2021 - 2033 (USD Million/Billion) Fig. 37 Regional marketplace: Key takeaways Fig. 38 North America RNAi technology market, by country, 2021 -2033 (USD Million/Billion) Fig. 39 U.S. RNAi technology market, 2021 - 2033 (USD Million/Billion) Fig. 40 Canada RNAi technology market, 2021 - 2033 (USD Million/Billion) Fig. 41 Mexico RNAi technology market, 2021 - 2033 (USD Million/Billion) Fig. 42 Europe RNAi technology market, by country, 2021 -2033 (USD Million/Billion) Fig. 43 UK RNAi technology market, 2021 - 2033 (USD Million/Billion) Fig. 44 Germany RNAi technology market, 2021 - 2033 (USD Million/Billion) Fig. 45 France RNAi technology market, 2021 - 2033 (USD Million/Billion) Fig. 46 Italy RNAi technology market, 2021 - 2033 (USD Million/Billion) Fig. 47 Spain RNAi technology market, 2021 - 2033 (USD Million/Billion) Fig. 48 Denmark RNAi technology market, 2021 - 2033 (USD Million/Billion) Fig. 49 Sweden RNAi technology market, 2021 - 2033 (USD Million/Billion) Fig. 50 Norway RNAi technology market, 2021 - 2033 (USD Million/Billion) Fig. 51 Asia-Pacific RNAi technology market, by country, 2021 -2033 (USD Million/Billion) Fig. 52 Japan RNAi technology market, 2021 - 2033 (USD Million/Billion) Fig. 53 China RNAi technology market, 2021 - 2033 (USD Million/Billion) Fig. 54 India RNAi technology market, 2021 - 2033 (USD Million/Billion) Fig. 55 Australia RNAi technology market, 2021 - 2033 (USD Million/Billion) Fig. 56 Thailand RNAi technology market, 2021 - 2033 (USD Million/Billion) Fig. 57 South Korea RNAi technology market, 2021 - 2033 (USD Million/Billion) Fig. 58 Latin America RNAi technology market, by country, 2021 -2033 (USD Million/Billion) Fig. 59 Brazil RNAi technology market, 2021 - 2033 (USD Million/Billion) Fig. 60 Argentina RNAi technology market, 2021 - 2033 (USD Million/Billion) Fig. 61 MEA RNAi technology market, by country, 2021 -2033 (USD Million/Billion) Fig. 62 South Africa RNAi technology market, 2021 - 2033 (USD Million/Billion) Fig. 63 Saudi Arabia RNAi technology market, 2021 - 2033 (USD Million/Billion) Fig. 64 UAE RNAi technology market, 2021 - 2033 (USD Million/Billion) Fig. 65 Kuwait RNAi technology market, 2021 - 2033 (USD Million/Billion)

提及公司

Thermo Fisher Scientific, Inc.Merck KGaACreative BiolabsGenScriptRevvityPromega CorporationOriGene Technologies, Inc.Altogen BiosystemsDanaherBioneer Corporation

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Grand View Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們